ACCORD HEALTHCARE LIMITED
Location
Founded
2004-04-13
Risk Signals
336 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ACCORD HEALTHCARE LIMITED
Live alerts from global media, monitored by Business Radar
2025-02-16 (cmshs-bloggt.de)
UPC: Overview of current judgments and developments -
The number of decisions of the uniform patent court (Unified Patent Court, UPC) increases steadily. Our overview represents the orders and decisions of the UPC.
Read more
2024-12-21 (juve-patent.com)
How long will Kirkland resist the UPC's courtrooms? -
Kirkland & Ellis' London patent litigation team is extremely successful, but at the UPC the team tends to pull the strings in the background.
Read more
2024-12-03 (medscape.com)
Diabetics the benefits of an intense reduction in blood pressure are confirmed
Intensive therapy aimed at lowering systolic blood pressure to 120 mm Hg in patients with type 2 diabetes reduced the risk of cardiovascular events compared to a standard treatment approach in the BPROAD trial.
Read more
2024-10-02 (thecable.ng)
Nigeria needs divine intervention, says Accord Party
The Accord Party (AP) has alleged that there is confusion in governance at all levels.
Read more
2024-09-30 (nature.com)
Enhancing severe hypoglycemia prediction in type 2 diabetes mellitus through multi-view co-training machine learning model for imbalanced dataset
Patients with type 2 diabetes mellitus (T2DM) who have severe hypoglycemia (SH) poses a considerable risk of long-term death, especially among the elderly, demanding urgent medical attention. Accurate prediction of SH remains challenging due to its multifaced nature, contributed from factors such as
Read more
2023-09-19 (chemistanddruggist.co.uk)
Hydrocortisone manufacturers face record £130m fine as appeal rejected
The Competition Appeal Tribunal (CAT) has upheld findings by the Competition and Markets Authority (CMA) against manufacturers in a hydrocortisone price hike case.
Read more
2022-12-13 (marketscreener.com)
Eagle Pharmaceuticals Reaches Settlement Agreement with Accord Healthcare, Inc. Related to BENDEKA | MarketScreener
Eagle Pharmaceuticals, Inc. today announced that it has reached a settlement agreement with Accord Healthcare, Inc. .Eagle had asserted its Orange Book-listed patents against Accord related to... | December 13, 2022
Read more
2022-08-29 (counselmagazine.co.uk)
Allergan, Inc and another company v Aspire Pharma Ltd; Accord Healthcare Ltd v Allergan, Inc
Patent – Infringement. The Patents Court held that the defendants' challenge to the validity of a patent for ophthalmic administration for the treatment of glaucoma succeeded.
Read more
2022-06-22 (jdsupra.com)
Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc. (Fed. Cir. 2022) | JD Supra
The Federal Circuit recently granted a panel rehearing and vacated a panel decision between these parties decided earlier this year (see Novartis...
Read more